The Board of OncoSil Medical Ltd. announced the appointment of Dr. Ralph Peters as Chief Medical Officer and Mr. David Turner as Head of Medical Affairs. As Chief Medical Officer of OncoSil, Dr. Peters will be responsible for the development and implementation of clinical strategy while providing medical oversight and clinical support to the broader team. He will be responsible for leading interactions with thought leaders and other relevant stakeholders. As Head of Medical Affairs, Mr. Turner will be responsible for liaising with key opinion leaders and institutions to promote the Company's device, including engaging with regulators and external parties in relation to clinical data. Dr. Ralph Peters joined the Company in January 2021, bringing with him over 30 years' experience in the field of interventional radiology. Most recently, from 2005 to 2020, Ralph served as EMEA Medical Director of Sirtex Medical Limited. Mr. David Turner joined OncoSil Medical in January 2021 and has over 40 years' experience in the pharmaceutical, medical device, and health technology industries. Prior to joining the Company, David served as Global Head of Marketing for Sirtex Medical Limited.